Breaking News

Amgen Invests $365M in New Biomanufacturing Plant in Ohio

Product assembly and packaging plant will support production of medicines for the U.S. and is expected to be operational by 2024.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Amgen broke ground for its newest biomanufacturing plant in New Albany, OH. The final product assembly and packaging plant will support production of medicines for the U.S. and is expected to be operational by 2024.   Arleen Paulino, senior vice president of Manufacturing at Amgen, said the reasons Amgen selected the Columbus region, “The positive business climate, access to a growing and diverse talent pool and the convenience from a logistics perspective were all important factors in o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters